Anti-Tnf Biosimilars Indicated for Rheumatoid Arthritis are Increasingly Available in Europe- How Do Payers and Key Stakeholders Perceive Them?
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2656
https://www.valueinhealthjournal.com/article/S1098-3015(14)04605-1/fulltext
Title :
Anti-Tnf Biosimilars Indicated for Rheumatoid Arthritis are Increasingly Available in Europe- How Do Payers and Key Stakeholders Perceive Them?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04605-1&doi=10.1016/j.jval.2014.08.2656
First page :
A388
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
361